07:00 , Jul 24, 2000 |  BioCentury  |  Finance

Restarting the IPO engine

The industry priced $540.6 million of IPO paper last week, helped by the rebound in the sector and solid earnings from the big cap companies. While last month's proclamation of the mapping of the human...
07:00 , Sep 7, 1999 |  BC Week In Review  |  Company News

Cambridge Molecular, Whatman deal

Whatman, a separations technology business, will acquire Cambridge Molecular for £4 million ($6.4 million) in cash. Cambridge Molecular provides contract DNA purification services. Cambridge Molecular Technologies Ltd., Cambridge, U.K.   Whatman plc, Maidstone, U.K.  ...
07:00 , Jul 6, 1998 |  BC Week In Review  |  Company News

Cambridge Molecular, Hexagen deal

Cambridge Molecular will perform DNA extraction services on human blood samples to support one of Hexagen's disease gene discovery programs. Cambridge Molecular Technologies Ltd. , Cambridge, U.K.   Hexagen plc , Cambridge, U.K.   Business:...
07:00 , Jun 8, 1998 |  BC Week In Review  |  Company News

Cambridge Molecular sales and marketing update

Cambridge launched its Camgen Genomic Extraction Kits that yield genomic DNA from whole blood, blood lymphocytes, cultured cells or tissues. Cambridge Molecular Technologies Ltd., Cambridge, U.K.   Business: Enabling technology  ...
07:00 , Oct 20, 1997 |  BioCentury  |  Finance

European private rounds

European private rounds Acadia Pharmaceuticals (formerly Receptor Technologies) $13.5M Danish subsidiary of San Diego high throughput screening company raises funds from Danish consortium including Dansk Kapitalanlog, BankInvest, Lonmodtagernes Dyrtidsfond and Kommuernes Pensionforsikring and Vokstfonden, Denmark's...
07:00 , Oct 13, 1997 |  BC Week In Review  |  Company News

Cambridge Molecular management update

Cambridge Molecular Technologies Ltd., Cambridge, U.K.   Business: Enabling technology   Hired: John McQuillian as CEO, formerly U.K. general manager and business development director for PE Applied Biosystems  ...
07:00 , Oct 6, 1997 |  BC Week In Review  |  Company News

Cambridge Molecular sales and marketing update

Cambridge Molecular began U.K. sales of its AutoPrep-12, an automated DNA extraction system that produces plasmid DNA from bacterial cultures. AutoPrep can produce 8?µg of plasmid DNA in 15 minutes from 1-3 ml of starting...
07:00 , Jul 15, 1996 |  BioCentury  |  Emerging Company Profile

DIAD: Prodrugs are better

One of the continuing challenges of drug research is to develop medications that are more precisely targeted against unhealthy cells. Such targeting kills two birds with one stone: enabling drugs to reach target cells and...